Shareholders exercise their right to decide on Moberg Pharma’s affairs at the AGM, which must be held within six months of fiscal year-end; Moberg Pharma's AGM is normally held in late April. The AGM considers several central issues such as adoption of Moberg Pharma’s income statement and balance sheet for the past year, dividend, board and auditor election, discharging the board from liability, and board and auditor remuneration.